Comprehensive Due Diligence & Regulatory Compliance Services for Healthcare Organizations

Integrated Due Diligence & Regulatory Oversight: Securing Your Healthcare Investment

The Bottom Line for Investors and C-Suite Executives:
In the Life Sciences sector, regulatory failure is the primary cause of M&A devaluation and post-market collapse. Traditional financial due diligence often misses the “hidden” technical risks—such as poor Data Integrity or unvalidated software—that can lead to FDA consent decrees.

The Eran Yona Advantage: My 360-degree due diligence integrates Regulatory Inspection Readiness with Operational Excellence, ensuring that your target acquisition is not only compliant today but scalable and profitable tomorrow.

At the intersection of healthcare innovation and regulatory compliance lies the critical need for thorough due diligence and expert regulatory oversight. Our specialized services combine deep industry expertise with comprehensive regulatory knowledge to support pharmaceutical companies, medical device manufacturers, and E-Health enterprises in navigating complex compliance landscapes while optimizing business operations.

Why Choose Our Due Diligence Services?

In today’s rapidly evolving healthcare landscape, regulatory compliance and business excellence are inseparable. Our unique approach integrates regulatory inspection expertise with business due diligence, providing a 360-degree assessment that ensures both compliance and operational efficiency. We understand that each subsector of the healthcare industry faces distinct challenges, from pharmaceutical manufacturing to digital health solutions.

Our Comprehensive Due Diligence Services

1. Regulatory Compliance Assessment

We conduct thorough evaluations of your compliance status across all relevant regulatory frameworks, including:

FDA, EMA, and international regulatory requirements
GMP, GCP, and GLP compliance verification
Data integrity and documentation systems
Quality management system effectiveness
Standard Operating Procedures (SOPs) review and optimization
Risk management system assessment
Validation status of critical systems

2. Business Operations Due Diligence

Our business assessment goes beyond traditional due diligence to identify opportunities for operational excellence:

Process efficiency evaluation
Supply chain resilience assessment
Quality control systems optimization
Resource allocation analysis
Technology infrastructure assessment
Operational risk identification
Cost optimization opportunities

3. E-Health Specific Due Diligence Services

For digital health companies, we offer specialized evaluation of:

Data protection compliance (GDPR, HIPAA, ISO 27001, ISO 27799)
Cybersecurity measures
Software validation processes
Electronic systems verification
Digital health regulations compliance
Medical device software classification
Remote healthcare delivery compliance

Our Due Diligence Methodology

We employ a systematic, risk-based approach that combines:

Phase	Action	Outcome
Initial Assessment	Comprehensive review of documentation and systems.	Baseline compliance profile.
Gap Analysis	Identification of compliance gaps and business risks.	Risk prioritization matrix.
On-site Inspections	Thorough evaluation of facilities and operations.	Physical verification of “paper” quality.
Expert Consultation	Strategic recommendations for improvement.	Actionable business intelligence.
Implementation Support	Guidance for corrective actions (CAPA).	Path to remediation.
Follow-up Reviews	Ensuring sustained compliance and improvement.	Long-term investment security.

Value Proposition & Industry Expertise

Our services deliver tangible benefits: reduced regulatory risks, enhanced operational efficiency, strengthened quality systems, and improved investor confidence.

Our team brings decades of combined experience in pharmaceutical manufacturing, medical device development, clinical research operations, and healthcare technology assessment.

We recognize that each organization has unique needs.

Our solutions are tailored to company size, market access goals, resource constraints, and organizational culture.

We go beyond traditional due diligence to ensure that compliance measures enhance rather than hinder business operations.

Why Act Now?

In an increasingly complex regulatory environment, proactive due diligence is essential for preventing costly compliance issues, maintaining market competitiveness, protecting brand reputation, and ensuring patient safety.

We are committed to delivering objective assessments, practical recommendations, and actionable insights.

Frequently Asked Questions (FAQ)

Q: How does Eran Yona’s due diligence differ from standard financial audits?
A: While financial audits look at the books, I look at the technical integrity. I evaluate if the manufacturing lines, the software code, and the lab data actually meet the stringent requirements of the FDA and EMA—factors that can make or break a company’s valuation.

Q: Can you support a company during an active M&A process?
A: Yes. I provide rapid-response technical due diligence for buyers or sellers to identify “deal-breaker” regulatory risks or to validate the technical strengths of a target company.

Q: What is “Technical Due Diligence” for E-Health?
A: It involves reviewing the Software Development Life Cycle (SDLC), cybersecurity protocols (HIPAA/GDPR), and ensuring the software is correctly classified and validated as a medical device under MDR or FDA regulations.